Vanguard Portfolio Management’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$44.9M Sell
2,465,334
-61,468
-2% -$1.23M ﹤0.01% 1718
2026
Q2
$57.1M Buy
2,526,802
+105,440
+4% +$2.64M ﹤0.01% 1682
2026
Q1
$60.6M Buy
+2,421,362
New +$68.2M ﹤0.01% 1613

Other funds holding PRCT

Vanguard Portfolio Management's PRCT Position: Q3 2026 in Review

Vanguard Portfolio Management reduced its Procept Biorobotics (PRCT) stake by 2.4% in Q3 2026, selling an estimated $1.23M and leaving 2,465,334 shares worth $44.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1718.

Vanguard Portfolio Management first reported a position in PRCT in Q1 2026 and has held it in 3 quarters since. The position peaked at $60.6M in Q1 2026. 229 funds tracked by Wall St. Rank hold PRCT as of Q3 2026.

  • Vanguard Portfolio Management held 2,465,334 shares of Procept Biorobotics worth $44.9M as of Q3 2026.
  • Vanguard Portfolio Management sold 61,468 Procept Biorobotics shares in Q3 2026, an estimated $1.23M.
  • Procept Biorobotics made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q3 2026, its #1718 holding.
  • Vanguard Portfolio Management first reported a position in Procept Biorobotics in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Portfolio Management's Procept Biorobotics position peaked at $60.6M in Q1 2026.
  • 229 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2026.

Based on Vanguard Portfolio Management's 13F filing for Q3 2026, filed 13 Nov 2026.